Al-Hammadi’s 2014 net profit up 16% to SAR 129 mln
19/01/2015
Argaam Exclusive
View other reports
Al-Hammadi Development and Investment Company, a newly listed company, reported 2014’s net profit of SAR 129 million, a 16 percent increase compared to the last year.
A net profit of SAR 33.7 million was reported for Q4-2014 compared to SAR 25.4 million for Q3.
Financials (M)
| Item | 2013 | 2014 | Change |
|---|---|---|---|
| Revenues | 434.08 | 481.96 | 11.0 % |
| Gross Income | 185.16 | 209.11 | 12.9 % |
| Operating Income | 112.10 | 130.95 | 16.8 % |
| Net Income | 111.50 | 128.95 | 15.6 % |
| Average Shares | 160.00 | 160.00 | - |
| Earnings Per Share before unusual items (Riyals) | 0.70 | 0.81 | 15.6 % |
| EPS (Riyal) | 0.70 | 0.81 | 15.6 % |
The Company attributed the increase of 2014’s net profit compared to the same period last year to the growth of revenue income driven by the growth of the number patients as well as improving the operating efficiency.
Compared With The
Current Quarter Comparison (M)
| Item | Q4 2013 | Q4 2014 | Change |
|---|---|---|---|
| Revenues | 124.13 | 129.43 | 4.3 % |
| Gross Income | 55.17 | 55.99 | 1.5 % |
| Operating Income | 34.34 | 34.52 | 0.5 % |
| Net Income | 33.29 | 33.71 | 1.2 % |
| Average Shares | 160.00 | 160.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.21 | 0.21 | 1.2 % |
| EPS (Riyal) | 0.21 | 0.21 | 1.2 % |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2014 | 122.04 | 16.4 % | 54.71 | 15.6 % | 35.96 | 19.5 % |
| Q2 2014 | 121.66 | 11.8 % | 53.68 | 17.1 % | 35.77 | 57.3 % |
| Q3 2014 | 108.83 | 13.1 % | 44.74 | 21.5 % | 24.77 | 30.3 % |
| Q4 2014 | 129.43 | 4.3 % | 55.99 | 1.5 % | 34.52 | 0.5 % |
| 2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS(Riyal) |
|---|---|---|---|---|---|---|
| Q1 2014 | 34.23 | 14.7 % | 0.21 | - | 34.23 | 0.21 |
| Q2 2014 | 35.60 | 18.4 % | 0.22 | - | 35.60 | 0.22 |
| Q3 2014 | 25.42 | 38.7 % | 0.16 | - | 25.42 | 0.16 |
| Q4 2014 | 33.71 | 1.2 % | 0.21 | - | 33.71 | 0.21 |
| 2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2013 | - | - | - |
| Q2 2013 | - | - | - |
| Q3 2013 | - | - | - |
| Q4 2013 | 42.66 % | 27.60 % | 24.31 % |
| 2013 | 42.66 % | 28.96 % | 25.69 % |
| Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
| Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
| Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
| Q4 2014 | 43.39 % | 30.09 % | 26.75 % |
| 2014 | 43.39 % | 30.07 % | 26.75 % |
Compared With The
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Earnings Per Share before unusual items (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2014 | 160.00 | 0.72 | 0.69 | 3.87 |
| Q2 2014 | 160.00 | 0.76 | 0.76 | 7.88 |
| Q3 2014 | 160.00 | 0.80 | 0.80 | 8.04 |
| Q4 2014 | 160.00 | 0.81 | 0.81 | 8.25 |
Multiple Ratios (End of Period Price)
| Period | P/E | Recurring P/E | Price/book |
|---|---|---|---|
| Q1 2014 | - | - | - |
| Q2 2014 | - | - | - |
| Q3 2014 | 51.42 | 51.42 | 5.14 |
| Q4 2014 | 48.92 | 48.92 | 4.78 |
Business Segments (Million)
2014
| Period | Healthcare services | Pharmaceutical sales revenue - Pharmacies |
|---|
| Current | |
| Market Cap (M Riyal) | 5,574.41 |
| Enterprise Value (EV) (M Riyal) | 5,653.33 |
| Shares Outstanding ((M)) | 160.00 |
| EPS ( Riyal) (TTM) | 1.83 |
| Book Value (BV) ( Riyal) | 12.42 |
| Par Value ( Riyal) | 10.00 |
| Recurring P/E | 19.04 |
| P/E (TTM) | 19.04 |
| Price/book | 2.80 |
| Return on Average Assets (%) (TTM) | 11.2 |
| Return on Average Equity (%) (TTM) | 15.0 |
| EV/adj EBITDA | 15.27 |
| EV/Revenues | 4.66 |
Share Price
Al Hammadi Holding (ALHAMMADI)
Follow us on
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}